LABD:ARCA-Direxion Daily S&P Biotech Bear 3X Shares (USD)

ETF | Trading--Inverse Equity | NYSE Arca

Last Closing

USD 5.54

Change

-0.06 (-1.07)%

Market Cap

USD 0.10B

Volume

0.02B

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, creates short positions by investing at least 80% of its assets in: swap agreements; futures contracts; options; reverse repurchase agreements; exchange-traded funds ("ETFs"); and other financial instruments that, in combination, provide inverse leveraged and unleveraged exposure to the S&P Biotechnology Select Industry Index. The index includes domestic companies from the biotechnology industry. The fund is non-diversified.

Inception Date: 28/05/2015

Primary Benchmark: S&P Biotechnology Select Industry TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.55%

Management Expense Ratio: 1.00 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-29 )

Largest Industry Peers for Trading--Inverse Equity

Symbol Name Mer Price(Change) Market Cap
SH ProShares Short S&P500 0.89 %

-0.05 (-0.44%)

USD 1.03B
SOXS Direxion Daily Semiconductor B.. 0.97 %

-1.25 (-5.09%)

USD 0.94B
PSQ ProShares Short QQQ 0.95 %

-0.16 (-0.39%)

USD 0.74B
SPXU ProShares UltraPro Short S&P50.. 0.91 %

-0.39 (-1.46%)

USD 0.52B
SDOW ProShares UltraPro Short Dow30 0.95 %

-0.30 (-2.08%)

USD 0.32B
SPDN Direxion Daily S&P 500® Bear .. 0.45 %

-0.06 (-0.52%)

USD 0.18B
DOG ProShares Short Dow30 0.95 %

-0.18 (-0.65%)

USD 0.17B
RWM ProShares Short Russell2000 0.95 %

-0.49 (-2.44%)

USD 0.16B
FNGD MicroSectors FANG+ Index -3X I.. 0.00 %

-0.33 (-1.42%)

USD 0.14B
YANG Direxion Daily FTSE China Bear.. 1.02 %

-0.13 (-1.45%)

USD 0.13B

ETFs Containing LABD

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Inverse Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -42.83% 13% F 3% F
Dividend Return 1.60% 25% F 39% F
Total Return -41.22% 13% F 4% F
Trailing 12 Months  
Capital Gain -66.38% 7% C- 2% F
Dividend Return 2.62% 6% D- 39% F
Total Return -63.76% 7% C- 2% F
Trailing 5 Years  
Capital Gain -98.75% 9% A- N/A F
Dividend Return 0.50% 8% B- 1% F
Total Return -98.26% 9% A- N/A F
Average Annual (5 Year Horizon)  
Capital Gain 51.31% 70% C- 95% A
Dividend Return 52.10% 68% D+ 95% A
Total Return 0.80% 19% F 18% F
Risk Return Profile  
Volatility (Standard Deviation) 1,035.58% 30% F 1% F
Risk Adjusted Return 5.03% 61% D- 30% F
Market Capitalization 0.10B 63% D 27% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.